AUGX

Augmedix, Inc. [AUGX] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

AUGX Stock Summary

Earnings have grown 45.01% per last year.

An RSI reading of 70 or higher indicates an overbought or overvalued condition.

In the News

AUGX Financial details

Company Rating

Market Cap

185.7M

Income

-19.2M

Revenue

44.86M

Book val./share

Cash/share

Dividend

Dividend %

Employees

1.43K

Optionable

Shortable

Yes

Earnings

18 Mar 2024

P/E

-12.08

Forward P/E

PEG

3.28

P/S

6.32

P/B

336.76

P/C

P/FCF

-12.36

Quick Ratio

3.23

Current Ratio

3.23

Debt / Equity

LT Debt / Equity

EPS (TTM)

-0.45

EPS next Y

EPS next Q

EPS this Y

-38.03%

EPS next Y

EPS next 5Y

EPS last 5Y

-56.07%

Revenue last 5Y

26.03%

Revenue Q/Q

7.76%

EPS Q/Q

-5.37%

SMA20

1.74%

SMA50

SMA100

Inst Own

Inst Trans

ROA

-50%

ROE

-2728%

ROC

-0.66%

Gross Margin

47%

Oper. Margin

-50%

Profit Margin

-50%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

1.5-6.25

52W High

-60.83%

52W Low

+135%

RSI

70.28

Rel Volume

Avg Volume

374.62K

Volume

Perf Week

0.86%

Perf Month

Perf Quarter

Perf Half Y

3.52%

Beta

-0.126

Volatility

0.01%, 0.02%

Prev Close

Price

2.35

Change

0.43%

Something similar

Top by Market Cap

Same Sector

Check Those

Similar Market Cap

Company Profile

Volume Average 374.62K
Market Capitalization 185.7M
Employee 1.43K
CEO Mr. Emmanuel Krakaris
Headquarters San Francisco,CA,US
IPO Date 2021-03-31
Website https://www.augmedix.com

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.